MENU
CLDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Celldex Therapeutics (CLDX) Ownership - Who owns Celldex Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
53 Frontage Road
Phone
+1 908 200-7500
Employees
160
Web
https://www.celldex.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.73B
P/E Ratio
N/A
Total Cash
756M
Projected Growth
N/A
Total Debt
3.09M
Revenue
9.98M
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash/Share
11.40
Total Debt/Equity
N/A
Revenue/Share
0.16 USD as % of share price
Fundamentals
CLDX
Capitalization
1.73B
P/E Ratio
N/A
Risk (Beta)
1.22
Dividend Yield
N/A
Total Cash
756M
Total Cash/Share
11.40
Total Debt
3.09M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.16%
Revenue
9.98M
ROE
N/A
Book Value
786M
P/B Ratio
2.20
Cash Flow
N/A
Earnings
-2.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
66K
Current Ratio
24.27
Current Revenue Per Employee
19943.75
Dividends Per Share - Security
N/A
EBITDA
-171.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-27.93
Shares Held By Institutions
4.59B
Shares Outstanding - Current
66.3M
Total Liabilities
37.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-34.342
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of immunotherapy technologies for the treatment of cancer and other diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
53 Frontage Road
Phone
+1 908 200-7500
Employees
160
Web
https://www.celldex.com